<乌鸦传媒視頻>Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant Two studies had "important differences," but can help guide clinicians Feb 13, 2024
<乌鸦传媒視頻>Smoking Tied to Increased Mortality From Early-Stage Melanoma Association only see among current smokers, however Feb 06, 2024
<乌鸦传媒視頻>FDA Clears AI-Powered Non-Invasive Skin Cancer Detector Intended for use in primary care, handheld device is first of its kind Jan 17, 2024
<乌鸦传媒視頻>Futile Immunotherapy for Cancer Grows More Common Occurs most often at non-academic and low-volume centers Jan 04, 2024
<乌鸦传媒視頻>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS News, features, and commentary about cancer-related issues Oct 27, 2023
<乌鸦传媒視頻>Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC Follow-up results from phase II study show 12-month EFS rate of 89% in stage II-IV disease Oct 25, 2023
<乌鸦传媒視頻>Tebentafusp's OS Benefit in Uveal Melanoma Holds Up at 3 Years And early ctDNA reductions correlated with survival Oct 21, 2023
<乌鸦传媒視頻>What to Know About Merkel Cell Carcinoma, the Rare Cancer That Killed Jimmy Buffett An expert weighs in on what to know about the uncommon skin cancer Sep 06, 2023
<乌鸦传媒視頻>Jill Biden Has COVID; BA.2.86 Less Evasive Than Feared? Jimmy Buffett's Fatal Cancer Health news and commentary from around the Web gathered by 乌鸦传媒視頻 staff Sep 05, 2023
<乌鸦传媒視頻>Gut Microbiome Study Yields Clues to Melanoma Development, Progression Differences between patients and volunteers, early- vs late-stage may help guide management Aug 31, 2023
<乌鸦传媒視頻>Study Reinforces BRAF-MEK Inhibition Over Anti-BRAF Only in Advanced Melanoma Improved PFS with encorafenib-binimetinib versus encorafenib, but immunotherapy still top option Aug 29, 2023
<乌鸦传媒視頻>Mohs Surgery Best for Early-Stage Merkel Cell Carcinoma? Retrospective data suggest superior survival in pathologically confirmed node-negative disease Aug 23, 2023
<乌鸦传媒視頻>FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma Hepzato Kit melphalan delivery system produced objective responses in 36% of patients Aug 15, 2023
<乌鸦传媒視頻>Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma Absolute risk reduction of 9-10% in 1- and 2-year DFS compared with observation Jul 14, 2023
<乌鸦传媒視頻>Dermatologists Hone Diagnostic Accuracy for Suspect Lesions With AI 'Collaboration' Sensitivity, specificity, mean accuracy, and AUC improved significantly with neural network input May 16, 2023
<乌鸦传媒視頻>Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomas Results will likely "encourage a practice change," editorialists say May 10, 2023
<乌鸦传媒視頻>Responses to PD-1 Blockade Approach 90% in Rare Melanoma "One of the highest tumor response rates we've seen in any cancer," study discussant says Apr 17, 2023
<乌鸦传媒視頻>Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanoma Clinical implications apply to virtually all solid tumors and possibly hematologic malignancies Apr 17, 2023
<乌鸦传媒視頻>FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
<乌鸦传媒視頻>Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplant Randomized study finds no benefit with 12 months of nicotinamide versus placebo Mar 01, 2023
<乌鸦传媒視頻>Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanoma Encorafenib-binimetinib tops vemurafenib, but checkpoint inhibitors remain first-line choice Dec 19, 2022
<乌鸦传媒視頻>Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<乌鸦传媒視頻>Melanoma Resistant to Anti-PD-1 Responds to Tumor Infiltrating Lymphocytes Almost a third of patients had objective responses, which deepened over time, study showed Nov 16, 2022
<乌鸦传媒視頻>Mixed Results With Fecal Transplant to Stimulate Cancer Immunotherapy Response Encouraging activity with antibiotic-free protocol but not with vancomycin preconditioning Nov 14, 2022
<乌鸦传媒視頻>Terry Bradshaw's Merkel Cell Carcinoma After beating bladder cancer, the Hall of Fame quarterback was diagnosed with a rare skin tumor Nov 10, 2022
<乌鸦传媒視頻>Immunotherapy First for BRAF Melanoma Edges Out Targeted Combination "Clinically meaningful" improvement in 2- and 3-year survival Sep 28, 2022
<乌鸦传媒視頻>Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanoma Large increase in event-free survival with neoadjuvant plus adjuvant versus only adjuvant therapy Sep 13, 2022
<乌鸦传媒視頻>Neoadjuvant Cemiplimab Active in Resectable Cutaneous Squamous Cell Carcinoma Pathologic complete responses seen in 63% of patients in phase II data Sep 12, 2022
<乌鸦传媒視頻>Tumor Infiltrating Lymphocytes Reemerge as Potential Melanoma Option More than 50% increase in 6-month PFS versus ipilimumab after progression on first-line anti-PD-1 Sep 12, 2022
<乌鸦传媒視頻>Keytruda Plus T-VEC Falls Short in Unresectable Melanoma No significant survival benefit with combination, but certain patients lived longer Sep 02, 2022
<乌鸦传媒視頻>Are Skin Lesion Analyzers Ready for Prime Time? FDA panel not fully on board to reclassify computer-aided melanoma detection devices Jul 30, 2022
<乌鸦传媒視頻>TKI Plus Immunotherapy Active in Melanoma After Anti-PD-1 Progression More than a fifth of patients responded to lenvatinib-pembrolizumab combination Jul 26, 2022
<乌鸦传媒視頻>Something Fishy About Tuna and Melanoma Risk Higher total fish intake linked with 22% higher risk of malignant tumors Jun 09, 2022
<乌鸦传媒視頻>Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1 But response rate driven primarily by injected lesions, expert points out Apr 14, 2022
<乌鸦传媒視頻>Dual Immunotherapy Improves PFS in Melanoma Resistant to Anti-PD-1 Six-month PFS rate more than doubled with nivolumab/ipilimumab versus ipilimumab alone Apr 13, 2022
<乌鸦传媒視頻>Novel Fixed-Dose Immunotherapy Combo Wins FDA Approval Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
<乌鸦传媒視頻>Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer Nodal metastasis detected more often than by clinical exam, worrisome false-positive rate Mar 18, 2022
<乌鸦传媒視頻>Novel Therapies Active in Head and Neck Cancers High response rate with oncolytic virus plus immunotherapy in cutaneous lesions Feb 28, 2022
<乌鸦传媒視頻>Merkel Cell Carcinoma Much More Likely to Recur vs Other Skin Cancers 5-year recurrence rate was 40% compared with 19% for melanoma Feb 23, 2022
<乌鸦传媒視頻>Active Surveillance for Melanoma Meets Reality of Loss to Follow-Up More than a third of patients lost to follow-up in "real-world" experience Jan 10, 2022
